Cardiff Oncology (CRDF) Assets Average (2016 - 2025)
Historic Assets Average for Cardiff Oncology (CRDF) over the last 14 years, with Q3 2025 value amounting to $69.8 million.
- Cardiff Oncology's Assets Average rose 819.87% to $69.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.8 million, marking a year-over-year increase of 819.87%. This contributed to the annual value of $89.4 million for FY2024, which is 960.48% down from last year.
- Cardiff Oncology's Assets Average amounted to $69.8 million in Q3 2025, which was up 819.87% from $80.3 million recorded in Q2 2025.
- Cardiff Oncology's 5-year Assets Average high stood at $145.4 million for Q4 2021, and its period low was $64.5 million during Q3 2024.
- Its 5-year average for Assets Average is $105.7 million, with a median of $102.0 million in 2023.
- In the last 5 years, Cardiff Oncology's Assets Average soared by 96136.27% in 2021 and then plummeted by 3133.03% in 2024.
- Cardiff Oncology's Assets Average (Quarter) stood at $145.4 million in 2021, then decreased by 17.55% to $119.9 million in 2022, then dropped by 29.08% to $85.0 million in 2023, then decreased by 5.88% to $80.0 million in 2024, then decreased by 12.85% to $69.8 million in 2025.
- Its Assets Average stands at $69.8 million for Q3 2025, versus $80.3 million for Q2 2025 and $91.0 million for Q1 2025.